IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $303,000 | -22.9% | 15,583 | -34.0% | 0.00% | -33.3% |
| Q4 2017 | $393,000 | +58.5% | 23,599 | +173.9% | 0.00% | +50.0% |
| Q2 2016 | $248,000 | -5.3% | 8,615 | +5.2% | 0.00% | 0.0% |
| Q1 2016 | $262,000 | -4.4% | 8,191 | +27.9% | 0.00% | 0.0% |
| Q4 2015 | $274,000 | -6.8% | 6,404 | -23.3% | 0.00% | 0.0% |
| Q3 2015 | $294,000 | +143.0% | 8,351 | +216.9% | 0.00% | +100.0% |
| Q2 2015 | $121,000 | +26.0% | 2,635 | +28.5% | 0.00% | 0.0% |
| Q1 2015 | $96,000 | +47.7% | 2,051 | -0.6% | 0.00% | 0.0% |
| Q4 2014 | $65,000 | +16.1% | 2,063 | -13.0% | 0.00% | – |
| Q3 2014 | $56,000 | -24.3% | 2,370 | -3.3% | 0.00% | -100.0% |
| Q2 2014 | $74,000 | +13.8% | 2,452 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $65,000 | +6.6% | 2,452 | +0.5% | 0.00% | 0.0% |
| Q4 2013 | $61,000 | -64.5% | 2,440 | -70.9% | 0.00% | -50.0% |
| Q3 2013 | $172,000 | +95.5% | 8,389 | +89.5% | 0.00% | +100.0% |
| Q2 2013 | $88,000 | – | 4,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 560,400 | $9,022,000 | 3.93% |
| NORTH TIDE CAPITAL, LLC | 1,000,000 | $16,100,000 | 3.58% |
| Sivik Global Healthcare LLC | 250,000 | $4,025,000 | 1.47% |
| MAVERICK CAPITAL LTD | 7,159,336 | $115,265,000 | 1.44% |
| SECTOR GAMMA AS | 589,311 | $9,488,000 | 1.38% |
| BRIDGER MANAGEMENT, LLC | 1,341,143 | $21,592,000 | 1.23% |
| Eos Focused Equity Management, L.P. | 48,714 | $784,000 | 0.89% |
| Bridge City Capital, LLC | 47,194 | $760,000 | 0.64% |
| Fosun International Ltd | 300,000 | $4,830,000 | 0.60% |
| Century Capital Management, LLC | 203,138 | $3,271,000 | 0.56% |